282 related articles for article (PubMed ID: 14564478)
1. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
[TBL] [Abstract][Full Text] [Related]
2. Grade of bone marrow fibrosis is associated with relevant hematological findings-a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM
Ann Hematol; 2006 Apr; 85(4):226-32. PubMed ID: 16421727
[TBL] [Abstract][Full Text] [Related]
3. Analysis of risk factors of the evolution of myelofibrosis in pre-fibrotic chronic idiopathic myelofibrosis: a retrospective study based on follow up biopsies of 70 patients by using the RECPAM method.
Kreft A; Wiese B; Weiss M; Choritz H; Buhr T; Büsche G; Georgii A
Leuk Lymphoma; 2004 Mar; 45(3):553-9. PubMed ID: 15160918
[TBL] [Abstract][Full Text] [Related]
4. Prefibrotic chronic idiopathic myelofibrosis--a diagnostic enigma?
Thiele J; Kvasnicka HM
Acta Haematol; 2004; 111(3):155-9. PubMed ID: 15034237
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
[TBL] [Abstract][Full Text] [Related]
6. [The development of myelofibrosis in prefibrotic cIMF. An investigation of the progression by sequential bone marrow biopsies in 38 patients].
Buhr T; Länger F; Kreft A; Büsche G; Choritz H; Kreipe H
Pathologe; 2002 Nov; 23(6):433-7. PubMed ID: 12436296
[TBL] [Abstract][Full Text] [Related]
7. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
Buhr T; Büsche G; Choritz H; Länger F; Kreipe H
Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
[TBL] [Abstract][Full Text] [Related]
8. Hematopathologic findings in chronic idiopathic myelofibrosis.
Thiele J; Kvasnicka HM
Semin Oncol; 2005 Aug; 32(4):380-94. PubMed ID: 16202684
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features and prognostic factors in primary myelofibrosis patients under 45 years old].
Lu L; Xiao ZJ; Chen HS; Lin H; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):281-4. PubMed ID: 15949290
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood CD34 count in myelofibrosis with myeloid metaplasia: a prospective evaluation of prognostic value in 94 patients.
Arora B; Sirhan S; Hoyer JD; Mesa RA; Tefferi A
Br J Haematol; 2005 Jan; 128(1):42-8. PubMed ID: 15606548
[TBL] [Abstract][Full Text] [Related]
11. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
Thiele J; Kvasnicka HM; Zankovich R; Diehl V
Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
[TBL] [Abstract][Full Text] [Related]
12. Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.
Tefferi A; Huang J; Schwager S; Li CY; Wu W; Pardanani A; Mesa RA
Cancer; 2007 May; 109(10):2083-8. PubMed ID: 17407134
[TBL] [Abstract][Full Text] [Related]
13. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
Thiele J; Steinberg T; Zankovich R; Fischer R
Anticancer Res; 1989; 9(2):429-35. PubMed ID: 2751268
[TBL] [Abstract][Full Text] [Related]
14. The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera.
Kvasnicka HM; Thiele J
Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):362-71. PubMed ID: 16810612
[TBL] [Abstract][Full Text] [Related]
15. Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival.
Patnaik MM; Caramazza D; Gangat N; Hanson CA; Pardanani A; Tefferi A
Eur J Haematol; 2010 Feb; 84(2):105-8. PubMed ID: 19895568
[TBL] [Abstract][Full Text] [Related]
16. Rectal cancer surgery in the elderly: a multivariate analysis of outcome risk factors.
Bufalari A; Giustozzi G; Burattini MF; Servili S; Bussotti C; Lucaroni E; Ricci E; Sciannameo F
J Surg Oncol; 2006 Mar; 93(3):173-80. PubMed ID: 16482596
[TBL] [Abstract][Full Text] [Related]
17. [Study of 161 chronic idiopathic myelofibrosis patients for clinicopathological staging].
Liu AN; Chen HS; Liu EB; Fang LH; Yang QY; Qian LS
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):178-82. PubMed ID: 16792920
[TBL] [Abstract][Full Text] [Related]
18. Idiopathic myelofibrosis: a retrospective study of 103 patients.
Anger B; Seidler R; Haug U; Popp C; Heimpel H
Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
20. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
